Outpatient Foley For Starting Induction of Labor at Term in Nulliparous Women (OFFSITE II)

February 4, 2020 updated by: Elizabeth B. Ausbeck, University of Alabama at Birmingham

Outpatient Foley For Starting Induction of Labor at Term in Nulliparous Women: A Randomized-Controlled Study

The investigators are performing a randomized controlled trial investigating starting cervical ripening in the outpatient setting with a mechanical method, the transcervical Foley catheter. The objective of the study is to determine if outpatient compared to inpatient cervical ripening with a transcervical Foley catheter in nulliparous women undergoing induction shortens the time spent in labor and delivery (from the time of admission to the time of delivery).

Study Overview

Detailed Description

Approximately 20-25% of pregnant women undergo an induction of labor, and a large percentage of these women require cervical ripening in order to "ready" the cervix for induction. In the setting of an unfavorable cervix, induction of labor with oxytocin alone can be associated with longer times to delivery, uterine tachysystole (uterine contractions that are too frequent), and increased rates of cesarean delivery.

Outpatient cervical ripening is an attractive option for both women and their physicians, as this allows for the potential to spend less time in the hospital and more time in the comforts of the patient's own home.

The investigators will conduct a randomized controlled trial comparing outpatient to inpatient cervical ripening using a transcervical Foley catheter. Women will be randomized to undergo inpatient or outpatient transcervical Foley catheter cervical ripening beyond their 39th week of gestation. Women and their infants will be followed until the time of their discharge from the hospital.

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age ≥ 18
  • Nulliparous
  • Singleton gestation
  • Gestational age between 39+0 and 42+0 weeks
  • Vertex presentation
  • Modified Bishop score <5 and cervical dilation ≤ 2 cm
  • No prior cesarean or prior uterine surgery
  • Resides within 30 minutes of UAB Hospital
  • Access to a telephone
  • Reliable transportation

Exclusion Criteria:

  • Unsuitable for outpatient cervical ripening (e.g., IUGR, oligohydramnios, polyhydramnios, gestational hypertension or preeclampsia, complex maternal disease, provider discretion). Patients with well controlled Class A or B DM or chronic hypertension will be eligible.
  • Latex allergy
  • Contraindication to induction of labor
  • Evidence of labor
  • Fetal demise
  • Fetal anomaly
  • Inability to give consent (e.g., inability to read or write)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Inpatient cervical ripening group
Subjects in this arm will be seen in the outpatient setting, and if they qualify and are randomized to the inpatient (control) group, they will be admitted to labor and delivery the next day for cervical ripening with a transcervical Foley catheter.
Subjects will be randomized have cervical ripening with a transcervical Foley catheter in either the inpatient or outpatient setting.
ACTIVE_COMPARATOR: Outpatient cervical ripening group
Subjects in this arm will undergo cervical ripening with a transcervical Foley catheter in the outpatient setting (intervention arm). The transcervical catheter will be placed in the office after confirmation of fetal well-being. They will then return the next day to be admitted to labor and delivery for induction of labor with oxytocin.
Subjects will be randomized have cervical ripening with a transcervical Foley catheter in either the inpatient or outpatient setting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total time from admission to delivery
Time Frame: From baseline to the time of delivery (baseline is from admission)
From baseline to the time of delivery (baseline is from admission)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Bishop score on admission
Time Frame: At baseline
At baseline
Evaluation of patient satisfaction with care
Time Frame: Within 2-4 days after delivery
Assessed through survey adapted from "Six Simple Questions Survey," which has been published by Harvey et al (Harvey et al. Evaluation of satisfaction with midwifery care. Midwifery. 2002 Dec; 18(4):260-7.) This survey has 6 questions to assess perceptions of satisfaction with care. The questions include questions such as, "I had appropriate and adequate control over my care," "The person(s) responsible for my care are/were caring and compassionate," and "Problems that have arisen up to now have not been dealt with effectively." The scare ranges from 1-7, with 1 representing Strongly Disagree and 7 representing Strongly Agree.
Within 2-4 days after delivery
Evaluation of patient experience on labor and delivery
Time Frame: Within 2-4 days after delivery
Assessed through survey adapted from "Labor and Delivery Index (LADY-X" Survey, which has been published by Gartner et al (Gartner et al. Calculating Preference Weights for the Labor and Delivery Index: A Discrete Choice Experiment on Women's Birth Experiences. Value Health. 2015 Sep; 18(6):856-864.) This survey has 7 questions to assess experiences during labor and birth. Each question then has 3 answer choices that describe how good/poor the experience was. An example of a question is, "Taking your wishes seriously during childbirth." The answers then include "very seriously, sufficiently seriously, or insufficiently seriously."
Within 2-4 days after delivery
Evaluation of pain experienced during childbirth
Time Frame: From placement of Foley bulb to delivery
Assessed through survey that contains 4 questions. The first 3 questions assess pain (worst pain during labor, overall pain during labor, and worse pain during placement of the Foley balloon). The 4th question asks how likely a patient is to recommend her method of induction to a friend/family member. The scale ranges from 0-100, with 0 representing no pain or very unlikely and 100 representing pain as bad as it could possibly be or very likely. The patient is instructed to place a hash mark over the line.
From placement of Foley bulb to delivery
Vaginal bleeding greater than bloody show
Time Frame: From placement of Foley bulb to delivery
Vaginal bleeding that is like a period or more
From placement of Foley bulb to delivery
Total hospital duration
Time Frame: From hospital admission to hospital discharge (generally less than one week)
From hospital admission to hospital discharge (generally less than one week)
Rates of acetaminophen use
Time Frame: From placement of Foley bulb to 24 hours
From placement of Foley bulb to 24 hours
Rates of calls to the obstetrical triage unit
Time Frame: From placement of Foley bulb to 24 hours
From placement of Foley bulb to 24 hours
Early admission or early visit to the obstetrical triage unit prior to scheduled induction of labor time
Time Frame: From placement of Foley bulb to 24 hours
From placement of Foley bulb to 24 hours
Rates of spontaneous rupture of membranes between Foley bulb placement and admission
Time Frame: From placement of Foley bulb to 24 hours
From placement of Foley bulb to 24 hours
Non-reassuring fetal heart rate tracings 30-minutes after Foley bulb placement
Time Frame: From placement of Foley bulb to 30 minutes
From placement of Foley bulb to 30 minutes
Total duration of time of neuraxial anesthesia use
Time Frame: From baseline to delivery
From baseline to delivery
Total time of oxytocin infusion
Time Frame: From baseline to delivery
From baseline to delivery
Maximum oxytocin rate
Time Frame: From baseline to delivery
From baseline to delivery
Highest maternal intrapartum temperature
Time Frame: From baseline to delivery
From baseline to delivery
Rates of chorioamnionitis
Time Frame: From baseline to delivery
From baseline to delivery
Rates of endometritis
Time Frame: From delivery until 30 days post-discharge
From delivery until 30 days post-discharge
Mode of delivery
Time Frame: From baseline to delivery
Rates of vaginal delivery, cesarean delivery, and operative vaginal delivery (vacuum or forceps)
From baseline to delivery
Postpartum hemorrhage
Time Frame: At delivery
At delivery
Rates of hospital readmission within 30 days
Time Frame: From hospital discharge until 30 days post-discharge
From hospital discharge until 30 days post-discharge
Rates of 5-minute Apgar score <7
Time Frame: From time of delivery up to 5 minutes post-delivery
From time of delivery up to 5 minutes post-delivery
Rates of umbilical cord artery pH <7.1
Time Frame: From time of delivery up to 5 minutes post-delivery
From time of delivery up to 5 minutes post-delivery
Rates of umbilical cord artery base deficit <-12
Time Frame: From time of delivery up to 5 minutes post-delivery
From time of delivery up to 5 minutes post-delivery
Rates of neonatal intensive care unit admissions
Time Frame: After delivery and before neonatal discharge (generally less than one week)
After delivery and before neonatal discharge (generally less than one week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth B Ausbeck, MD, University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 4, 2018

Primary Completion (ACTUAL)

November 1, 2019

Study Completion (ACTUAL)

December 13, 2019

Study Registration Dates

First Submitted

February 12, 2018

First Submitted That Met QC Criteria

March 14, 2018

First Posted (ACTUAL)

March 21, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 6, 2020

Last Update Submitted That Met QC Criteria

February 4, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Transcervical Foley catheter placement for cervical ripening

3
Subscribe